Skip to content

PANDION THERAPEUTICS, INC.

CIK 0001807901

← back to feed
Revenue (TTM)
$8.78M
+807.9% YoY FY Mar 2021
Net Income (TTM)
−$32M
−74.2% YoY FY Mar 2021
EPS Diluted (TTM)
—
FY Mar 2021
Gross Margin
—
FY Mar 2021
Operating Margin
-363.1%
FY Mar 2021
Net Margin
-364.5%
FY Mar 2021
Free Cash Flow (TTM)
−$37.78M
FY Mar 2021
Cash
$219.89M
FY Mar 2021
Total Debt
—
FY Mar 2021
Shares Outstanding
29.52M sh
FY Mar 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings